1. Introduction {#sec1}
===============

Diabetic Peripheral Neuropathy (DPN) affects 50% of Type II diabetes patients \[[@bib1], [@bib2], [@bib3]\]. DPN is commonest symmetrical type of chronic complication with higher prevalence in individuals with higher percentage of glycosylated haemoglobin (HbA1C) \[[@bib4],[@bib5]\]. DPN individuals presents with neuropathic pain and altered neural mechanosensitivity, balance and gait problems \[[@bib6],[@bib7]\] due to impaired proprioception \[[@bib8]\], limited ankle joint movement and reduced muscle flexibility \[[@bib9],[@bib10]\].

The late detection, progression and treatment of DPN yields in the deterioration of the quality of life of the sufferers \[[@bib11]\]. Peripheral neuropathy can be detected through NCS, ultrasonography, and MRI \[[@bib12], [@bib13], [@bib14]\]. Diffusion Tensor Imaging (DTI) may be used as the assessment tool in the peripheral nerve related disease and also monitor reinnervation through fractional anisotropy (FA), apparent diffusion coefficient (ADC) \[[@bib15]\].

Hyperglycemia leads to the altered nerve biomechanics due to fluid accumulation in the nerve \[[@bib16]\] which can be targeted through nerve mobilization (NM) in the form of the neurodynamics and the nerve massage \[[@bib17], [@bib18], [@bib19]\]. The NM techniques are useful in restoring the normal physiological function through both the intraneural and extra neural effect \[[@bib20],[@bib21]\]. The purpose of current research is to explore the effect of NM on the DTI parameters in healthy individuals and in DPN patients.

2. Materials and methods {#sec2}
========================

2.1. Research design {#sec2.1}
--------------------

The study is a multigroup pretest-posttest design. [Fig. 1](#fig1){ref-type="fig"} shows an overview of this trial plan. The selection of the participants will be done randomly and informed consent will be obtained from the selected participants. The baseline and post treatment data for FA and ADC, pain and disability will be recorded using the MRI 1.5- Tesla MR System Multiva- Philips; VAS and universal goniometer respectively. During the treatment period participants will follow their medical treatment protocol without any alteration in their medical management; if there is any alteration then the patient will be excluded from further analysis and there data will be considered for analysis using intention to treat analysis method.Fig. 1Flow chart to show the protocol.Fig. 1

The study has been approved by Institutional Research Ethics Committee of Maharishi Markandeshwar (Deemed to be University), Mullana- Ambala, and Haryana, India. The trial is registered at Indian Clinical Trials Registry (CTRI/2019/06/019552) on 6/6/2019 and Universal Trial Number is U1111-1238-5094. The data will be collected from Outpatient Department of the Musculoskeletal Physiotherapy, Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation. The patients will be recruited from Maharishi Markandeshwar Institute of Medical Sciences and Research- Radiology Outpatient department.

2.2. Participants {#sec2.2}
-----------------

Patients with Type II Diabetes Mellitus induced peripheral neuropathy will be taken for the participation in the study. The selection of 90 patients will be done using the criteria -- based purposive sampling. Selection criteria are given in [Table 1](#tbl1){ref-type="table"}.Table 1Selection criteria for the study participation.Table 1Inclusion CriteriaExclusion CriteriaAged between 36 and 70 years.Diabetic foot ulcer and Neuropathic jointsIndividuals with unilateral or bilateral CSMDPN.History of cardiac pacemakers and MRI contraindications.Individuals with confirmed chronic sensory motor diabetic peripheral neuropathy (CSMDPN) diagnosed by physician as per diagnostic criteria \[[@bib22]\].Central nervous system and autonomic nervous system pathology.Individuals with Type II DM, with HbA1C \<10%.Diabetic foot ulcer and Neuropathic joints.Individuals who will give the informed consent.Any other co morbidities.

2.3. Randomization {#sec2.3}
------------------

Block randomization will be done. Random allocation of the eligible subjects for treatment will be done by the sealed opaque envelope method. We will make 6 blocks, with the matrix design of 6 × 15 (as shown in [Fig. 2](#fig2){ref-type="fig"}) here 15 being rows. Each block will contain 6 chits (3 chits for each group). The subjects will be allotted to the group based on the chits what they will pick. Once the box get empty, next box will be opened. Subjects will be randomized using the computer generated randomization method into three groups: Group A (NM + Conventional treatment) and Group B (Conventional treatment alone) and Group C (Sham intervention). Participants will be blinded before allocation into groups.Fig. 2Block Randomization (6 × 15 matrix design).Fig. 2

2.4. Intervention {#sec2.4}
-----------------

Nerve Mobilization Technique \[[@bib23]\] --•Slider technique ([Fig. 3](#fig3){ref-type="fig"}):Fig. 3Slider technique.Fig. 3

Proximal Sliding of the tibial nerve: Patient Position -- will be supine lying.Therapist Position -- will be standing by the side of the patient couch.

The therapist will hold the patient lower extremity in the horizontal position with the hip at 45° of flexion. The movement components to mobilize the nerve will be in a sequence of dorsiflexion (DF) and eversion (Ev) at the ankle and foot with DF of toes; knee extension and proper stabilization will be provided to the remaining lower extremity joints. At the end of the nerve bias, DF of the foot and toes will be released in the plantarflexion movement to allow the tibial nerve to slide proximally further.

Distal Sliding of the tibial nerve:Patient Position -- will be supine lying.Therapist Position -- will be standing by the side of the patient couch.

The therapist will hold the patient lower extremity in the horizontal position with the hip at 45° of flexion. The nerve will be moved into its mechanical interface distally by adding DF and Ev of the foot and also adding the DF of toes for releasing the proximal tension and allow the nerve to slide distally.•Tensioner technique of the tibial nerve ([Fig. 4](#fig4){ref-type="fig"}):Fig. 4Tensinor technique.Fig. 4Patient Position -- will be supine lying.Therapist Position -- will be standing by the side of the patient couch.

Movement Components -- Hip flexion 45° with ankle DF and foot Eversion with extension at knee joint.

The NM will be done by the experienced physiotherapist for 2 times/week for 3 weeks and the patients will receive 5 sets of 10 cycles with a rest period of 1 min in each set \[[@bib24]\].

Conventional Therapy:Nerve Massage \[[@bib25]\] ([Fig. 5](#fig5){ref-type="fig"})--Fig. 5Nerve massage along the nerve course.Fig. 5

Both the longitudinal and transverse nerve massage will be done by the experienced physiotherapist for 2 times/week for 3 weeks along the course of the tibial nerve (popliteal fossa to foot) for 4 min in total and the patients will receive total of 6 times for 10 repetitions.

Transcutaneous Electrical Nerve Stimulation (TENS) ([Fig. 6](#fig6){ref-type="fig"}) \[[@bib26]\] --Fig. 6Transcutaneous electrical nerve stimulation (TENS).Fig. 6

Patients will receive 10 sessions of TENS (80 Hz, 50 Amp, 0.2 ms square pulses, 2 to 3 times sensory threshold) every alternate day for 3 weeks for 20 min, with one electrode placement over the proximal tibia and other electrode over the ankle.

2.5. Outcome measures {#sec2.5}
---------------------

Demographic and anthropometric characteristics will be taken before the outcome measurements.

### 2.5.1. Primary outcomes {#sec2.5.1}

MRI technique will be performed by the experienced radiologist having more 10 years or more of experience using the 1.5- Tesla MR System Multiva- Philips magnet, Baltimore, Netherland, Holland with a typical spine/knee range loop with the magnetic field centered on the ankle joint. MRI scans of the conventional leg will also be done. The conventional MRI sequences will include axial and sagittal T2WSE and STIR for path anatomic relationship \[[@bib27]\]. Free -- breathing single -- shot echo -- planar Diffusion weighted images (DWI) neurography will be done by means of couple of b -- values of 0 and 800 s/mm^2^ respectively \[[@bib28]\]. ADC and FA data will be procured by adding the axial DWI and axial DTI sequences respectively.

### 2.5.2. Secondary outcomes {#sec2.5.2}

The Visual Analog Scale (VAS) is the pain measurement scale which is most commonly used with high reliability (ICC = 0.98). It is a 100 mm horizontal or vertical straight line with description of no pain at one end and worst pain on the other end of the line respectively. The patients will be instructed to report the intensity of pain experienced at that moment with a mark on the line. Pain measurement scoring is done in the millimeters from the no pain end of the scale to the mark by the patient on line \[[@bib29]\].

Neuropathy specific quality of life questionnaire (Neuro QoL) is used in the diabetic peripheral neuropathy patient\'s assessment and follows up after treatment intervention. It assesses the physical and emotional aspects related to quality of life and daily living of the diabetic neuropathy patients. Neuro QoL questionnaire is divided into six sub scales with total 27 questions having 5 -- point Likert scale for each question, where 1 represents "never" and 5 represents "all the time" frequency of symptoms. Six sub scale domains includes, pain and parasthesias; loss of temperature and object feeling in the feet; impaired standing and walking balance; restriction in activities of daily living; interpersonal physical and emotional dependence; emotional distress and two additional questions to assess the overall influence of neuropathy on life quality \[[@bib30]\].

2.6. Data monitoring {#sec2.6}
--------------------

Statistical analyses and datasets will be done by independent researcher to the group allocation examiner. Treatment sessions in each group will be monitored by the treating therapists.

2.7. Sample size {#sec2.7}
----------------

The sample size based on selection criteria will be 90 patients.

3. Data analysis {#sec3}
================

The Normality test, Kolmnogorov Smirnov will be used to check the normal distribution of the sample size. Appropriate statistical test will be used to achieve the aims of study like Mean, standard deviation (SD) and the level of significance (LOS) will be kept at 0.05 with 95% confidence interval (CI). Within the group analysis will be performed using repeated measures ANOVA if normal, otherwise Friedman test if not normal and between the group analysis will be done by independent t -- test if normal, or Mann U Whitney if not normal.

4. Discussion {#sec4}
=============

Diabetic neuropathy is a diagnosis of exclusion as suggested by the members of the International Consensus Meeting \[[@bib3]\]. It is characterized by the altered neural mechanosensitivity leading to the disturbed sensation in the extremity and foot resulting in the poor quality of life and disability \[[@bib6], [@bib7], [@bib8]\]. Peripheral neuropathies can be diagnosed with various investigative tools like ultrasonography, NCV and MRI \[[@bib12]\].

The previous literature have shown the efficacy and effectiveness of nerve mobilization and conventional physiotherapy in the improvement of conduction parameters \[[@bib20],[@bib21]\]. However, it remains unclear in the literature existed the effect of nerve mobilization and conventional physiotherapy in dissipating the neural edema in the patients with diabetic neuropathy; therefore, this experimental trial will help to provide the neural mobilization impact on the free water proton diffusion detected through the diffusion tensor imaging values in the posterior tibial nerve. The results obtained from the clinical trial will help to improve the nerve health in the diabetic population and hence will protect them to undergo foot and extremity amputations.

Diabetic neuropathy is a common significant complication in the diabetic population \[[@bib1]\]. The primary goal of this clinical trial is to evaluate the efficacy of nerve mobilization in improving the nerve sensitivity measured through diffusion tensor imaging. Furthermore, upon completion of this trial the evidence of nerve mobilization in the pain management in diabetic neuropathy will be strengthened by the Diffusion tensor imaging values in the posterior tibial nerve.
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